Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wee Loon Ong

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
World Journal of Urology|November 3, 2023
The march toward single-fraction stereotactic body radiotherapy for localized prostate cancer-Quo Vadimus?Wee Loon Ong, Andrew Loblaw
Brachytherapy|January 27, 2023
Late, persistent, substantial treatment-related symptoms (LAPERS) following low-dose-rate brachytherapy for prostate cancerWee Loon Ong, Jeremy Millar
Brachytherapy|December 27, 2016
Decline in acute urinary toxicities with increased institutional experience: 15-year experience of permanent seed prostate brachytherapy in a single Australasian institutionWee Loon Ong, Bronwyn Matheson, Jeremy Millar
The Journal of Sexual Medicine|April 8, 2015
Prevalence of Baseline Erectile Dysfunction (ED) in an Australian Cohort of Men with Localized Prostate CancerWee Loon Ong, Hamish McLachlan, Jeremy L Millar
Journal of Medical Imaging and Radiation Oncology|December 23, 2017
Under-utilisation of high-dose-rate brachytherapy boost in men with intermediate-high risk prostate cancer treated with external beam radiotherapyWee Loon Ong, Sue M Evans, Jeremy L Millar
Seminars in Radiation Oncology|March 29, 2023
Stereotactic Body Radiation Therapy for Spinal Metastases: Benefits and LimitationsMatthias Guckenberger, Max Dahele, Wee Loon Ong, et al.
BJU International|August 29, 2015
Clinicopathological characteristics and management of prostate cancer in the human immunodeficiency virus (HIV)-positive population: experience in an Australian major HIV centreWee Loon Ong, Paul Manohar, Jeremy Millar, et al.
BJU International|July 28, 2017
Large institutional variations in use of androgen deprivation therapy with definitive radiotherapy in a population-based cohort of men with intermediate- and high-risk prostate cancerWee Loon Ong, Farshad Foroudi, Sue Evans, et al.
Clinical and Translational Radiation Oncology|September 2, 2022
Real-world utilisation of brachytherapy boost and patient-reported functional outcomes in men who had external beam radiation therapy for prostate cancer in AustraliaWee Loon Ong, Melanie Evans, Nathan Papa, et al.
Journal of Medical Imaging and Radiation Oncology|October 9, 2018
Androgen deprivation therapy use with post-prostatectomy radiotherapy in the Prostate Cancer Outcomes Registry VictoriaWee Loon Ong, Farshad Foroudi, Sue Evans, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
World Journal of Urology|November 3, 2023
The march toward single-fraction stereotactic body radiotherapy for localized prostate cancer-Quo Vadimus?Wee Loon Ong, Andrew Loblaw
Brachytherapy|January 27, 2023
Late, persistent, substantial treatment-related symptoms (LAPERS) following low-dose-rate brachytherapy for prostate cancerWee Loon Ong, Jeremy Millar
Brachytherapy|December 27, 2016
Decline in acute urinary toxicities with increased institutional experience: 15-year experience of permanent seed prostate brachytherapy in a single Australasian institutionWee Loon Ong, Bronwyn Matheson, Jeremy Millar
The Journal of Sexual Medicine|April 8, 2015
Prevalence of Baseline Erectile Dysfunction (ED) in an Australian Cohort of Men with Localized Prostate CancerWee Loon Ong, Hamish McLachlan, Jeremy L Millar
Journal of Medical Imaging and Radiation Oncology|December 23, 2017
Under-utilisation of high-dose-rate brachytherapy boost in men with intermediate-high risk prostate cancer treated with external beam radiotherapyWee Loon Ong, Sue M Evans, Jeremy L Millar
Seminars in Radiation Oncology|March 29, 2023
Stereotactic Body Radiation Therapy for Spinal Metastases: Benefits and LimitationsMatthias Guckenberger, Max Dahele, Wee Loon Ong, et al.
BJU International|August 29, 2015
Clinicopathological characteristics and management of prostate cancer in the human immunodeficiency virus (HIV)-positive population: experience in an Australian major HIV centreWee Loon Ong, Paul Manohar, Jeremy Millar, et al.
BJU International|July 28, 2017
Large institutional variations in use of androgen deprivation therapy with definitive radiotherapy in a population-based cohort of men with intermediate- and high-risk prostate cancerWee Loon Ong, Farshad Foroudi, Sue Evans, et al.
Clinical and Translational Radiation Oncology|September 2, 2022
Real-world utilisation of brachytherapy boost and patient-reported functional outcomes in men who had external beam radiation therapy for prostate cancer in AustraliaWee Loon Ong, Melanie Evans, Nathan Papa, et al.
Journal of Medical Imaging and Radiation Oncology|October 9, 2018
Androgen deprivation therapy use with post-prostatectomy radiotherapy in the Prostate Cancer Outcomes Registry VictoriaWee Loon Ong, Farshad Foroudi, Sue Evans, et al.
Pageof 7